FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1202-1203 April 22, 1993 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: On November 29, 1992, Dennis Byrd, a football player with the New York Jets, suffered a serious spinal cord injury when he collided with a teammate during a game. According to reports by the news media, Byrd was treated at Lenox Hill Hospital in New York with an experimental drug^1,2. These reports dismay researchers such as myself, who are conducting randomized, controlled trials of treatments for such injuries. The drug, GM-1 ganglioside, is an experimental therapy for spinal injury³. It has shown sufficient promise in a pilot study to warrant investigation in an ongoing phase . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.